Before co-culturing with cancer cells, both OKT3 and anti-PSMA/anti-CD3 (scFv-Fab) BsAb-armed T cells expressed similar levels of surface CD25 (< 5%) and PD-1 (< 2%). This evidence concerns the gene FOLH1 and cancer.